Validation of de_novo mutations in human trios-sc-2010-08-18
Validation of de_novo mutations in human trios
Validation of de_novo mutations in trios. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria), please see http://www.sanger.ac.uk/datasharing/
Putatitive de_novo variants have been called in the offspring of the YRI and CEU trios used in the high depth study of the 1000 genomes project. Targeted Sequencing is being carried out to validate these de_novo calls.